Beta Bionics, Inc.
BBNX
$22.26
$1.778.64%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.87M | -28.66M | -18.11M | -- | -14.46M |
| Total Depreciation and Amortization | 653.00K | 604.00K | 529.00K | -- | 576.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.12M | 14.55M | 6.54M | -- | 4.34M |
| Change in Net Operating Assets | -1.50M | -6.47M | -3.24M | -- | -2.69M |
| Cash from Operations | -13.59M | -19.98M | -14.28M | -- | -12.24M |
| Capital Expenditure | -1.78M | -333.00K | -561.00K | -- | -507.00K |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00 | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.95M | -178.79M | -29.10M | -- | 3.81M |
| Cash from Investing | 6.17M | -179.12M | -29.66M | -- | 3.30M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 42.00K | 211.12M | 38.00K | -- | 12.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 59.66M | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -2.81M | -- | -119.00K |
| Cash from Financing | 42.00K | 211.12M | 56.89M | -- | -107.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.38M | 12.02M | 12.95M | -- | -9.04M |